Management of Hyperparathyroidism and Gout

Introduction to Hyperparathyroidism and Gout

• Patients with hyperparathyroidism have a 3-fold increased risk of developing gout compared to those without calcium pyrophosphate deposition disease, according to the American College of Rheumatology 1

Immediate Management of Acute Gout Attack

• For acute gout flares, the American College of Rheumatology recommends colchicine 1 mg loading dose, then 0.5 mg one hour later, as first-line treatment 2
• The American College of Rheumatology also recommends oral corticosteroids, such as prednisolone 30-35 mg/day for 3-5 days, if colchicine is contraindicated 2

Definitive Treatment of Hyperparathyroidism

• No cited facts are available for this section

Concurrent Urate-Lowering Therapy Initiation

• The American College of Rheumatology recommends starting allopurinol at 100 mg daily and increasing by 100 mg every 2-4 weeks until serum uric acid <6 mg/dL (360 μmol/L) 2

Mandatory Flare Prophylaxis During ULT Initiation

• The American College of Rheumatology recommends colchicine 0.5-1 mg daily as first-line prophylaxis for the first 6 months when starting allopurinol 2

Medication Review and Optimization

• The American College of Rheumatology recommends reviewing all medications for urate-raising effects and discontinuing thiazide or loop diuretics if possible, as these are the most common iatrogenic cause of gout 2

Lifestyle Modifications

• The American College of Rheumatology recommends comprehensive lifestyle counseling, including weight loss if obese, elimination of alcohol, and avoidance of sugar-sweetened drinks and high-fructose foods 2

Monitoring Strategy

• The American College of Rheumatology recommends targeting serum uric acid <6 mg/dL lifelong and checking serum urate levels every 2-4 weeks during dose titration 2

Critical Pitfalls to Avoid

• The American College of Rheumatology recommends not stopping urate-lowering therapy during acute flares, as this perpetuates the cycle of recurrent attacks 2